⌘K

Home/Filings/4/0000899243-17-005889

4//SEC Filing

Kite Pharma, Inc. 4

Accession 0000899243-17-005889

CIK 0001510580operating

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 6:06 AM ET

Size

11.4 KB

Accession

0000899243-17-005889

Insider Transaction Report

Form 4

Period: 2017-03-01

Kite Pharma, Inc.KITE

Director

Transactions

Sale
Common Stock
2017-03-01$72.27/sh−10,000$722,673→ 121,017 total
Exercise/Conversion
Common Stock
2017-03-01$1.35/sh+50,000$67,500→ 75,065 total
Sale
Common Stock
2017-03-01$76.77/sh−2,800$214,942→ 25,065 total(indirect: By Spouse)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-03-01−50,000→ 75,065 total
Exercise: $1.35Exp: 2024-03-24→ Common Stock (50,000 underlying)
Sale
Common Stock
2017-03-01$77.03/sh−6,000$462,200→ 115,017 total

Footnotes (1)

[F1]1/36th of the shares subject to the stock option vested immediately, and the remaining shares vested in 35 equal monthly installments commencing March 31, 2014.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kite Pharma, Inc.

CIK 0001510580

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001510580

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 6:06 AM ET
Size: 11.4 KB

View on SEC.gov